Get started
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

LINCOLN chart


Full chart

LINCOLN upcoming earnings


Next report date
≈
May 21
Report period
Q2 2020
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪11.33 B‬ INR
Dividend yield (indicated)
0.32%
Price to earnings Ratio (TTM)
12.65
Basic EPS (TTM)
44.60 INR
Net income (FY)
‪933.05 M‬ INR
Revenue (FY)
‪5.72 B‬ INR
Shares float
‪9.92 M‬
Beta (1Y)
2.23

Employees


Employees (FY)
‪1.69 K‬
Change (1Y)
−13 −0.76%
Revenue / Employee (1Y)
‪3.39 M‬ INR
Net income / Employee (1Y)
‪553.08 K‬ INR

About LINCOLN PHARMA LTD


Sector
Health Technology
CEO
Mahendrabhai Gulabda Patel
Headquarters
Ahmedabad
Website
lincolnpharma.com
Founded
1979
ISIN
INE405C01035
FIGI
BBG000GMHMS6
Lincoln Pharmaceuticals Ltd. is a holding company, which engages in the manufacture and sale of pharmaceutical products. It focuses on different sectors such as cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin's, analgesic, and iron preparations. The company was founded in 1979 and is headquartered in Ahmedabad, India.

Financials


Performance
‪10.0%‬
‪12.5%‬
‪15.0%‬
‪17.5%‬
‪20.0%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪450.00 M‬‬
‪‪900.00 M‬‬
‪‪1.35 B‬‬
‪‪1.80 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪400.00 M‬‬
‪‪800.00 M‬‬
‪‪1.20 B‬‬
‪‪1.60 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪400.00 M‬‬
‪‪800.00 M‬‬
‪‪1.20 B‬‬
‪‪1.60 B‬‬
Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪90.00 M‬‬
‪‪180.00 M‬‬
‪‪270.00 M‬‬
‪‪360.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:May 21, 2025
Q4 '19
Q1 '20
Q2 '20
‪0.00‬
‪1.60‬
‪3.20‬
‪4.80‬
‪6.40‬
Actual
Estimate

LINCOLN news



No news here

Looks like there's nothing to report right now

Reload

Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of LINCOLN is 521.05 INR — it has decreased by −7.66% in the past 24 hours. Watch LINCOLN PHARMA LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange LINCOLN PHARMA LTD stocks are traded under the ticker LINCOLN.
LINCOLN stock has fallen by −7.45% compared to the previous week, the month change is a −23.38% fall, over the last year LINCOLN PHARMA LTD has showed a −24.27% decrease.
We've gathered analysts' opinions on LINCOLN PHARMA LTD future price: according to them, LINCOLN price has a max estimate of 1,008.00 INR and a min estimate of 1,008.00 INR. Watch LINCOLN chart and read a more detailed LINCOLN PHARMA LTD stock forecast: see what analysts think of LINCOLN PHARMA LTD and suggest that you do with its stocks.
LINCOLN reached its all-time high on Dec 9, 2024 with the price of 979.50 INR, and its all-time low was 85.05 INR and was reached on Mar 19, 2020. View more price dynamics on LINCOLN chart.
See other stocks reaching their highest and lowest prices.
LINCOLN stock is 9.50% volatile and has beta coefficient of 2.23. Track LINCOLN PHARMA LTD stock price on the chart and check out the list of the most volatile stocks — is LINCOLN PHARMA LTD there?
Today LINCOLN PHARMA LTD has the market capitalization of ‪11.33 B‬, it has decreased by −3.37% over the last week.
Yes, you can track LINCOLN PHARMA LTD financials in yearly and quarterly reports right on TradingView.
LINCOLN PHARMA LTD is going to release the next earnings report on May 21, 2025. Keep track of upcoming events with our Earnings Calendar.
LINCOLN net income for the last quarter is ‪207.69 M‬ INR, while the quarter before that showed ‪263.30 M‬ INR of net income which accounts for −21.12% change. Track more LINCOLN PHARMA LTD financial stats to get the full picture.
Yes, LINCOLN dividends are paid annually. The last dividend per share was 1.80 INR. As of today, Dividend Yield (TTM)% is 0.32%. Tracking LINCOLN PHARMA LTD dividends might help you take more informed decisions.
LINCOLN PHARMA LTD dividend yield was 0.31% in 2023, and payout ratio reached 3.86%. The year before the numbers were 0.44% and 4.12% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Mar 1, 2025, the company has ‪1.69 K‬ employees. See our rating of the largest employees — is LINCOLN PHARMA LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LINCOLN PHARMA LTD EBITDA is ‪931.57 M‬ INR, and current EBITDA margin is 16.40%. See more stats in LINCOLN PHARMA LTD financial statements.
Like other stocks, LINCOLN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LINCOLN PHARMA LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LINCOLN PHARMA LTD technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LINCOLN PHARMA LTD stock shows the sell signal. See more of LINCOLN PHARMA LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.